AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitorFeng Ren, Alex Zhavoronkov, Vladimir Naumov et al.|Chemical Science|2023Cited by 322
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical modelsFeng Ren, Alex Zhavoronkov, Evgeny Izumchenko et al.|Nature Biotechnology|2024Cited by 265
PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker DiscoveryPetrina Kamya, Alex Zhavoronkov, Vladimir Naumov et al.|Journal of Chemical Information and Modeling|2024Cited by 125
Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery PlatformFrank W. Pun, Alex Zhavoronkov, Anastasia Shneyderman et al.|Frontiers in Aging Neuroscience|2022Cited by 99
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engineFrank W. Pun, Alex Zhavoronkov, Evgeny Izumchenko et al.|Aging|2022Cited by 82